Nanjing Well Pharmaceutical Group Co.,Ltd. Stock
Equities
603351
CNE100003JD4
Oil & Gas Refining and Marketing
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.68 CNY | +2.41% | +7.59% | -6.41% |
Sales 2021 | 1.04B 144M 197M | Sales 2022 | 1.11B 153M 210M | Capitalization | 2.93B 405M 554M |
---|---|---|---|---|---|
Net income 2021 | 101M 13.95M 19.08M | Net income 2022 | 95M 13.12M 17.94M | EV / Sales 2021 | 5.01 x |
Net Debt 2021 | 107M 14.83M 20.28M | Net Debt 2022 | 325M 44.91M 61.41M | EV / Sales 2022 | 2.93 x |
P/E ratio 2021 |
51.5
x | P/E ratio 2022 |
30.5
x | Employees | 658 |
Yield 2021 |
0.77% | Yield 2022 |
1.29% | Free-Float | 36.34% |
1 day | +2.41% | ||
1 week | +7.59% | ||
Current month | +9.74% | ||
1 month | +9.74% | ||
3 months | +4.58% | ||
6 months | -6.09% | ||
Current year | -6.41% |
Managers | Title | Age | Since |
---|---|---|---|
Ren Rong Wu
CEO | Chief Executive Officer | 61 | 00-01-31 |
Qun Song Tang
DFI | Director of Finance/CFO | 56 | 00-01-31 |
Rong Wen Wu
CHM | Chairman | 58 | 00-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ya Mei Guan
BRD | Director/Board Member | 54 | 23-05-17 |
Ren Rong Wu
CEO | Chief Executive Officer | 61 | 00-01-31 |
Zheng Song Gao
CTO | Chief Tech/Sci/R&D Officer | 58 | 00-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 24.68 | +2.41% | 1,375,316 |
24-04-29 | 24.1 | +1.43% | 700,370 |
24-04-26 | 23.76 | -1.53% | 724,500 |
24-04-25 | 24.13 | +2.51% | 499,850 |
24-04-24 | 23.54 | -1.05% | 459,108 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-6.41% | 462M | |
+13.47% | 238B | |
+10.65% | 105B | |
+12.96% | 100B | |
+23.31% | 63.06B | |
+8.06% | 59.44B | |
+21.03% | 50.9B | |
+23.52% | 36.1B | |
+33.54% | 27.86B | |
-10.53% | 21.12B |
- Stock Market
- Equities
- 603351 Stock